Long-term cost-effectiveness of thrombectomy for acute ischaemic stroke in real life: An analysis based on data from the Swedish Stroke Register (Riksstroke)

Abstract

Background

Randomised controlled trials have demonstrated substantial clinical benefit for thrombectomy in patients with acute ischaemic stroke and proximal anterior circulation arterial occlusion.

Aim

We investigated the long-term cost-effectiveness of thrombectomy after thrombolysis versus thrombolysis alone using real-world outcome data on need for health care, home help and nursing home care.

Methods

We used real-life resource use and survival data from the Swedish Stroke Register and pooled outcomes from five randomised controlled trials published in 2015 in a newly constructed Markov cost-effectiveness model with a societal perspective. Data were stratified by age (18–64; 65–74; 75–84 years) and modified Rankin scale at three months for patients with an index ischaemic stroke in 2014 fulfilling inclusion criteria NIHSS ≥ 8 before treatment and treated with thrombolysis (n = 710). Univariate sensitivity analyses explored robustness of results. A life-time perspective and 3% discount rate were applied.

Results

Thrombectomy increases the health care cost per patient (+GBP 9000) mainly because of intervention costs, but the reduced burden on the social services (home help services −GBP 13,000; nursing home care −GBP 26,000) implies overall cost savings. The average patient gain was 1.0 quality-adjusted life year (QALY) with higher gains for younger age groups. Thrombectomy was a dominant strategy in the base case and all sensitivity analyses where social services were considered.

Conclusion

Thrombectomy has a small effect on hospital costs except for the direct intervention cost. However, thrombectomy is highly likely to lead to substantial cost savings in the social service sector, up to four times the increase in health-care costs.

Keywords

Endovascular thrombectomy acute ischaemic stroke long term cost-effectiveness burden on social services

Get full access to this article

View all access options for this article.

References

Berkhemer

Fransen

Beumer

et al.

A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015; 372: 11–20.

Bracard

Ducrocq

Mas

et al.

Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurol 2016; 15: 1138–1147.

Campbell

Mitchell

Kleinig

et al.

Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 2015; 372: 1009–1018.

Goyal

Demchuk

Menon

et al.

Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015; 372: 1019–1030.

Jovin

Chamorro

Cobo

et al.

Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 2015; 372: 2296–2306.

Saver

Goyal

Bonafe

et al.

Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 2015; 372: 2285–2295.

Casaubon

Boulanger

J-M

Blacquiere

et al.

Canadian Stroke Best Practice Recommendations: Hyperacute Stroke Care Guidelines, Update 2015. Int J Stroke 2015; 10: 924–940.

Lavine

Cockroft

Hoh

et al.

Training guidelines for endovascular stroke intervention: an international multi-society consensus document. Neuroradiology 2016; 58: 537–541.

Powers

Derdeyn

Biller

et al.

2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2015; 46: 3020–3035.

10.

Campbell

BCV

Donnan

Lees

et al.

Endovascular stent thrombectomy: the new standard of care for large vessel ischaemic stroke. The Lancet Neurol 2015; 14: 846–854.

11.

Aronsson

Persson

Blomstrand

Wester

Levin

. Cost-effectiveness of endovascular thrombectomy in patients with acute ischemic stroke. Neurology 2016; 86: 1053–1059.

12.

Ganesalingam

Pizzo

Morris

Sunderland

Ames

Lobotesis

. Cost-utility analysis of mechanical thrombectomy using stent retrievers in acute ischemic stroke. Stroke 2015; 46: 2591–2598.

13.

Leppert

Campbell

Simpson

Burke

. Cost-effectiveness of intra-arterial treatment as an adjunct to intravenous tissue-type plasminogen activator for acute ischemic stroke. Stroke 2015; 46: 1870–1876.

14.

Mangla

O'Connell

Kumari

Shahrzad

. Novel model of direct and indirect cost-benefit analysis of mechanical embolectomy over IV tPA for large vessel occlusions: a real-world dollar analysis based on improvements in mRS. J Neurointerv Surg 2016; 8: 1312–1316.

15.

Slot

Berge

Dorman

et al.

Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies. BMJ 2008; 336: 376–379.

16.

Eriksson

Norrving

Terent

Stegmayr

. Functional outcome 3 months after stroke predicts long-term survival. Cerebrovasc Dis 2008; 25: 423–429.

17.

Magalhaes

Abreu

Correia

Whiteley

Silva

Sandercock

. Functional status three months after the first ischemic stroke is associated with long-term outcome: data from a community-based cohort. Cerebrovasc Dis 2014; 38: 46–54.

18.

Hardie

Hankey

Jamrozik

Broadhurst

Anderson

. Ten-year risk of first recurrent stroke and disability after first-ever stroke in the Perth Community Stroke Study. Stroke 2004; 35: 731–735.

19.

Husereau

Drummond

Petrou

et al.

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Value Health 2013; 16: e1–e5.

20.

Riksstrokes årsrapport 2015 på 2014 års data (in Swedish) [Annual report of Riksstroke 2015 using year 2014 data]. The Swedish Stroke Register, http://www.riksstroke.org/sve/forskning-statistik-och-verksamhetsutveckling/forskning/arsrapporter/ (accessed 23 June 2016).

21.

Heldner

Zubler

Mattle

et al.

National Institutes of Health stroke scale score and vessel occlusion in 2152 patients with acute ischemic stroke. Stroke 2013; 44: 1153–1157.

22.

Andsberg G, Norrving B, Ullberg T and Undrén P. Trombektomi med stent retrievers vid akut ischemisk stroke. Health technology assessment (HTA) (in Swedish) [Thrombectomy with stent retrievers for acute ischaemic stroke. Health technology assessement]. Region Skåne, 2015.

23.

Rivero-Arias

Ouellet

Gray

Wolstenholme

Rothwell

Luengo-Fernandez

. Mapping the modified Rankin scale (mRS) measurement into the generic EuroQol (EQ-5D) health outcome. Med Decis Making 2010; 30: 341–354.

24.

Tandvårds- och läkemedelsförmånsverket [The Dental and Pharmaceutical Benefits Agency]. Hälsoekonomisk utvärdering av trombektomi för behandling av akut svår ischemisk stroke (in Swedish) [Health economic evaluation of thrombectomy in the treatment of acute severe ischaemic stroke]. The Dental and Pharmaceutical Benefits Agency, http://www.tlv.se/Medicinteknik/Medicinteknikuppdraget/avslutade-halsoekonomiska-bedomningar/Halsoekonomisk-utvardering-av-trombektomi/ (accessed 29 October 2015).

25.

Sveus. Värdebaserad uppföljning av strokevård – analys från framtagande av nya uppföljningssystem (in Swedish) [Value based accounting in stroke care - analyses using data from the development of new accounting systems]. Sveus [A national collaboration on value based reimbursment and accounting in health care], http://www.sveus.se/publikationer/rapporter/strokevard (accessed 14 September 2015).

26.

Socialstyrelsen [the National Board of Health and Welfare]. Äldre - vård och omsorg 1 oktober 2012 – Kommunala insatser enligt socialtjänstlagen samt hälso- och sjukvårdslagen (in Swedish) [Care and services to elderly persons October 1, 2012 – Interventions by the municipalities by the Social Services Act and by the Health Care Act]. Socialstyrelsen, http://www.socialstyrelsen.se/publikationer2013. (accessed 15 September 2015).

27.

Eriksson

Appelros

Norrving

Terént

Stegmayr

. Assessment of functional outcome in a national quality register for acute stroke: can simple self-reported items be transformed into the Modified Rankin Scale? Stroke 2007; 38: 1384–1386.

28.

Fischer

Arnold

Nedeltchev

et al.

NIHSS score and arteriographic findings in acute ischemic stroke. Stroke 2005; 36: 2121–2125.

29.

Cooray

Fekete

Mikulik

Lees

Wahlgren

Ahmed

. Threshold for NIH stroke scale in predicting vessel occlusion and functional outcome after stroke thrombolysis. Int J Stroke 2015; 10: 822–829.

30.

Heldner

Hsieh

Broeg-Morvay

et al.

Clinical prediction of large vessel occlusion in anterior circulation stroke: mission impossible?

J Neurol 2016; 263: 1633–1640.

31.

Vanacker

Heldner

Amiguet

et al.

Prediction of large vessel occlusions in acute stroke: National Institute of Health Stroke Scale Is Hard to Beat. Crit Care Med 2016; 44: e336–e343.

32.

Svensson

Ghatnekar

Lindgren

et al.

Societal value of stem cell therapy in stroke – a modeling study. Cerebrovasc Dis 2012; 33: 532–539.

33.

Södra regionvårdsnämnden [South Swedish Region Board]. Regionala priser och ersättningar för södra sjukvårdsregionen (in Swedish) [Regional prices and reimbursment for South Swedish Health Care Region]. Södra regionvårdsnämnden, http://sodrasjukvardsregionen.se/avtal-priser/regionala-priser-och-ersattningar (accessed 12 February 2015).

34.

Skånes universitetssjukhus [Skåne University Hospital]. Hospital accounts, own calculations. 2015.

35.

Kostnad per brukare (in Swedish) [Cost per user]. Sveriges kommuner och landsting SKL [The Swedish Association of Local Authorities and Regions], https://skl.se/ekonomijuridikstatistik/statistik/kostnadperpatientkpp/kppdatabas.1079.html (accessed 15 September 2015).

36.

Statistikdatabasen [the Statistical Database]. Statistiska centralbyrån [Statistics Sweden], http://www.statistikdatabasen.scb.se/ (accessed 21 August 2015).

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.37 MB